Dr. Matt Rowan received a grant titled, "Altering cortical inhibition to counteract neurodegeneration in Alzheimer's disease", from AUTIFONY THERAPEUTICS LTD.
The award is in the amount of $136,707.00.
Learn More about Autifony
Learn more about the Autifony Alzheimer's Disease Programme >>